(Total Views: 642)
Posted On: 01/28/2025 9:29:51 AM
Post# of 156175
The ART + bnAbs NIH grant started in 2014. In that annually renewed grant, in July 2020, Leronlimab is also listed in the description making it the Triple Therapy. https://reporter.nih.gov/search/Id1ufB4fiEmnZ...escription
This pre-dates the announcement of a 3rd party AI partner which I believe was in
November 2023.
https://www.cytodyn.com/newsroom/press-releas...areholders
"We also began development of a longer-acting therapeutic with a partner who has a very strong and reputable artificial intelligence (“AI”) platform, which we believe may provide significant increases in shareholder value in the years to come."
This pre-dates the announcement of a 3rd party AI partner which I believe was in
November 2023.
https://www.cytodyn.com/newsroom/press-releas...areholders
"We also began development of a longer-acting therapeutic with a partner who has a very strong and reputable artificial intelligence (“AI”) platform, which we believe may provide significant increases in shareholder value in the years to come."
(4)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
